A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

Detection of bladder cancer with aberrantly fucosylated ITGA3




TekijätIslam Md Khirul, Syed Parvez, Dhondt Bert, Gidwani Kamlesh, Pettersson Kim, Lamminmäki Urpo, Leivo Janne

KustantajaAcademic Press Inc Elsevier Science

Julkaisuvuosi2021

JournalAnalytical Biochemistry

Tietokannassa oleva lehden nimiANALYTICAL BIOCHEMISTRY

Lehden akronyymiANAL BIOCHEM

Artikkelin numeroARTN 114283

Vuosikerta628

Sivujen määrä5

ISSN0003-2697

eISSN1096-0309

DOIhttps://doi.org/10.1016/j.ab.2021.114283

Verkko-osoitehttps://www.sciencedirect.com/science/article/pii/S0003269721001846?via%3Dihub

Rinnakkaistallenteen osoitehttps://research.utu.fi/converis/portal/detail/Publication/66651036


Tiivistelmä

We describe a simple, non-invasive assay to identify fucosylated-glycoisoform of integrin alpha-3 (ITGA3) directly from unprocessed urine. ITGA3 was detected directly from the urine of bladder cancer (BlCa) (n = 13) and benign prostatic hyperplasia (BPH) (n = 9) patients with the use of lectins coated on europium-dopednanoparticles (Eu3+-NPs). Lectin Ulex europaeus agglutinin-I (UEA) showed enhanced binding with BlCaderived ITGA3. The evaluation with individual samples showed that a glycovariant ITGA3-UEA assay could significantly discriminate BlCa from BPH patients (p = 0.007). The detection of aberrantly fucosylated-isoform of ITGA3 from urine can be used to distinguish BlCa from age-matched benign controls in a simple sandwich assay.


Ladattava julkaisu

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2024-26-11 at 23:22